A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

NCT03988335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Palmoplantar Pustulosis

Interventions

DRUG: RIST4721
DRUG: Placebo

Sponsor

Aristea Therapeutics, Inc.